Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis.

Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology. 2007 Apr 17; 68(16):1299-304.

View in: PubMed

Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.